Join to View Full Profile
2802 McLamb PlGoldsboro, NC 27534
Phone+1 919-734-7265
Fax+1 919-734-6421
Dr. Kerlin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Kevin J. Kerlin, MD, FACRO, is a Radiation Oncologist based in Goldsboro, NC. He completed his medical education at UMDNJ-New Jersey Medical School, followed by a transitional internship at St Barnabas Medical Center and a residency in Radiation Oncology at UMDNJ-Robert Wood Johnson Medical School. Dr. Kerlin has served as the Medical Director at Wayne Radiation Oncology since 1992. His research contributions include several influential publications that have been widely cited, particularly in the areas of prostate cancer, breast cancer, and glioblastoma. His professional recognitions include being named a Fellow of the American College of Radiation Oncology and receiving CMS Meaningful Use Stage 1 Certification.
Education & Training
Rutgers Health/Robert Wood Johnson Medical SchoolResidency, Radiation Oncology, 1989 - 1992
Cooperman Barnabas Medical CenterInternship, Transitional Year, 1988 - 1989- Rutgers New Jersey Medical SchoolClass of 1988
Certifications & Licensure
NC State Medical License 1992 - 2025
NJ State Medical License 1989 - 1993
American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- America's Best Physicians http://www.todaysbestphysicians.com/index.php
- Fellow American College of Radiation Oncology, 2005
- CMS Meaningful Use Stage 1 Certification ARIA Radiation Oncology EMR, Varian Medical Systems, 2013-2014
Publications & Presentations
PubMed
- 445 citationsRadiation with or without Antiandrogen Therapy in Recurrent Prostate CancerWilliam U. Shipley, W. Seiferheld, H. Lukka, Pierre Major, Niall M. Heney
The New England Journal of Medicine. 2017-02-01 - 55 citationsA Phase 3 Trial of 2 Years of Androgen Suppression and Radiation Therapy With or Without Adjuvant Chemotherapy for High-Risk Prostate Cancer: Final Results of Radiatio...Seth A. Rosenthal, Daniel Hunt, A. Oliver Sartor, Kenneth J. Pienta, Leonard G. Gomella
International Journal of Radiation Oncology, Biology, Physics. 2015-10-01 - 260 citationsRTOG 9804: A Prospective Randomized Trial for Good-Risk Ductal Carcinoma In Situ Comparing Radiotherapy With ObservationBeryl McCormick, Kathryn Winter, Clifford A. Hudis, Henry Mark Kuerer, Eileen Rakovitch
Journal of Clinical Oncology. 2015-03-01
Professional Memberships
- Member
- Member
- American College of Radiation OncologyFellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
